Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Lake Street Private Wealth LLC

Lake Street Private Wealth LLC decreased its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 13.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,175 shares of the real estate investment trust’s stock after selling 2,803 shares during the period. Lake Street Private Wealth LLC’s holdings in Omega Healthcare Investors were worth $740,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OHI. Versant Capital Management Inc purchased a new stake in Omega Healthcare Investors in the 2nd quarter valued at approximately $26,000. UMB Bank n.a. raised its position in Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 516 shares during the period. DiNuzzo Private Wealth Inc. purchased a new position in Omega Healthcare Investors in the third quarter valued at about $33,000. WFA Asset Management Corp purchased a new position in Omega Healthcare Investors in the first quarter valued at about $39,000. Finally, V Square Quantitative Management LLC increased its position in shares of Omega Healthcare Investors by 49.5% during the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after acquiring an additional 323 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Analyst Ratings Changes

OHI has been the topic of a number of analyst reports. Truist Financial lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. BMO Capital Markets boosted their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Finally, Scotiabank increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus target price of $37.80.

Omega Healthcare Investors Trading Up 0.4 %

OHI traded up $0.15 during trading on Wednesday, reaching $41.39. 161,379 shares of the company’s stock were exchanged, compared to its average volume of 1,643,426. The firm has a fifty day moving average price of $39.86 and a two-hundred day moving average price of $35.42. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $41.73. The stock has a market capitalization of $10.67 billion, a PE ratio of 31.48, a price-to-earnings-growth ratio of 1.34 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. During the same period in the prior year, the company posted $0.74 earnings per share. The company’s revenue for the quarter was up 17.5% compared to the same quarter last year. As a group, equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.